News

Company continues to advance QRX003 in late-stage clinical trials in Netherton Syndrome patients Regulatory milestone ...
Shares of Quoin Pharmaceuticals surged 47.5% Wednesday morning. The stock is higher following the release of promising ...
Detailed price information for Quoin Pharmaceuticals Ltd ADR (QNRX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Quoin Pharmaceuticals Ltd ADR (QNRX-Q) from The Globe and Mail including charting and trades.
Analysts anticipate Quoin Pharmaceuticals to report an earnings per share (EPS) of $-4.20. Anticipation surrounds Quoin ...
With that task comes finances, a reshuffling of personnel, and the toughest of emotionless decisions to be taken within the ...
With every final goal contribution, you cannot blame many fans for wondering whether Manchester City are making a monumental error in letting go of arguably the club ...
The company, which trades under the ticker (NASDAQ:QNRX), had previously fallen below this threshold. Currently trading at $6.77, the stock has experienced significant volatility, with a 52-week range ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...